Inherited Metabolic Disorders Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 80 pages | ID: I6A206A0E2BEN
VPAResearch

Abstracts

Inherited Metabolic Disorders ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Inherited Metabolic Disorders disease clinical trials. The research work analyzes the ongoing Inherited Metabolic Disorders clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Inherited Metabolic Disorders treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Inherited Metabolic Disorders clinical trials.

Scope of the Report-

• Ongoing Inherited Metabolic Disorders clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Inherited Metabolic Disorders
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Inherited Metabolic Disorders clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Inherited Metabolic Disorders Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Inherited Metabolic Disorders Trials by Phase
3.2 Ongoing Inherited Metabolic Disorders Trials by Type
3.3 Ongoing Inherited Metabolic Disorders Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Inherited Metabolic Disorders Trials
4.2 Top 10 Countries conducting Inherited Metabolic Disorders Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Inherited Metabolic Disorders Trials by Sponsor Type
5.2 Inherited Metabolic Disorders Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Inherited Metabolic Disorders Trials by year
6.2 Subjects Recruited for Inherited Metabolic Disorders Trials by Phase
6.3 Subjects Recruited for Inherited Metabolic Disorders Trials by Trial Type
6.4 Subjects Recruited for Inherited Metabolic Disorders Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Inherited Metabolic Disorders Trials- Phase
7.2 Ongoing Inherited Metabolic Disorders Trials- Phase
7.3 Ongoing Inherited Metabolic Disorders Trials- Phase
7.4 Ongoing Inherited Metabolic Disorders Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Inherited Metabolic Disorders- Clinical Trials by Country
Figure 2: Inherited Metabolic Disorders- Clinical Trials by Phase of Development, 2018
Figure 3: Inherited Metabolic Disorders- Clinical Trials by Status, 2018
Figure 4: Inherited Metabolic Disorders- Clinical Trials by Type, 2018
Figure 5: Inherited Metabolic Disorders- Clinical Trials Split by Region, 2000-2018
Figure 6: Inherited Metabolic Disorders- Clinical Trials by Type of Economy, 2018
Figure 7: Inherited Metabolic Disorders- Enrolment by Phase, 2018
Figure 8: Inherited Metabolic Disorders- Enrolment by Trial Type, 2018
Figure 9: Inherited Metabolic Disorders- Enrolment by Recruitment Status, 2018
Figure 10: Inherited Metabolic Disorders- Clinical Trials by Sponsor Type, 2018
Figure 11: Inherited Metabolic Disorders- Enrolment by Type of Sponsors
Figure 12: Inherited Metabolic Disorders- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Inherited Metabolic Disorders- Clinical Trials by Sponsor Type, 2018
Table 2: Inherited Metabolic Disorders- Clinical Trials by Economy Type, 2018
Table 3: Inherited Metabolic Disorders- Clinical Trials by Region, 2018
Table 4: Inherited Metabolic Disorders- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Inherited Metabolic Disorders- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Inherited Metabolic Disorders- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Inherited Metabolic Disorders- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Inherited Metabolic Disorders- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Inherited Metabolic Disorders- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company